Evidence map›Paper›PMID 37296152›Full record

ArticleNature communications2023

Cryo-EM structures of ClC-2 chloride channel reveal the blocking mechanism of its specific inhibitor AK-42.

Tao Ma, Lei Wang, Anping Chai, Chao Liu, Wenqiang Cui, Shuguang Yuan, Shannon Wing Ngor Au, Liang Sun, Xiaokang Zhang, Zhenzhen Zhang and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Identification of a novelFrontiers in genetics · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Tao Ma *Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 518055, Shenzhen, China.
Lei Wang *School of Life Sciences, Southern University of Science and Technology, 518055, Shenzhen, China.ORCID 0000-0001-8044-7184
Anping Chai *Shenzhen Key Laboratory of Translational Research for Brain Diseases, The Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.ORCID 0000-0003-4651-7307
Chao LiuDepartment of Biomedical Engineering, Southern University of Science and Technology, 518055, Shenzhen, China.
Wenqiang CuiShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 518055, Shenzhen, China.
Shuguang YuanShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 518055, Shenzhen, China.ORCID 0000-0001-9858-4742
Shannon Wing Ngor AuSchool of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Liang SunShenzhen Shuli Tech Co., Ltd, 518126, Shenzhen, Guangdong, China.
Xiaokang ZhangShenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions, 518055, Shenzhen, Guangdong, China.
Zhenzhen ZhangDepartment of Biomedical Engineering, Southern University of Science and Technology, 518055, Shenzhen, China.
Jianping LuDepartment of Child and Adolescent Psychiatry, Shenzhen Kangning Hospital, Shenzhen Mental Health Center, Shenzhen, 518020, China.
Yuanzhu GaoCryo-EM Facility Center, Southern University of Science and Technology, 518055, Shenzhen, Guangdong, China.
Peiyi WangCryo-EM Facility Center, Southern University of Science and Technology, 518055, Shenzhen, Guangdong, China.ORCID 0000-0001-7737-181X
Zhifang LiDepartment of Biomedical Engineering, Southern University of Science and Technology, 518055, Shenzhen, China.
Yujie LiangDepartment of Child and Adolescent Psychiatry, Shenzhen Kangning Hospital, Shenzhen Mental Health Center, Shenzhen, 518020, China.
Horst VogelShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 518055, Shenzhen, China. horst.vogel@siat.ac.cn.ORCID 0000-0001-9695-8894
Yu Tian WangShenzhen Key Laboratory of Translational Research for Brain Diseases, The Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China. wangyt@siat.ac.cn.ORCID 0000-0001-8592-0698
Daping WangDepartment of Biomedical Engineering, Southern University of Science and Technology, 518055, Shenzhen, China. wangdp@mail.sustech.edu.cn.ORCID 0000-0002-2402-8134
Kaige YanSchool of Life Sciences, Southern University of Science and Technology, 518055, Shenzhen, China. yankg@sustech.edu.cn.ORCID 0000-0003-4176-5109
Huawei ZhangShenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 518055, Shenzhen, China. zhanghw@sustech.edu.cn.ORCID 0000-0002-5625-5809
Southern University of Science and Technology · CNChinese Academy of Sciences · CNShenzhen KangNing Hospital · CNChinese University of Hong Kong · HKHKUST Shenzhen Research Institute · CNShenzhen Metro (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ClC-2 transports chloride ions across plasma membranes and plays critical roles in cellular homeostasis. Its dysfunction is involved in diseases including leukodystrophy and primary aldosteronism. AK-42 was recently reported as a specific inhibitor of ClC-2. However, experimental structures are still missing to decipher its inhibition mechanism. Here, we present cryo-EM structures of apo ClC-2 and its complex with AK-42, both at 3.5 Å resolution. Residues S162, E205 and Y553 are involved in chloride binding and contribute to the ion selectivity. The side-chain of the gating glutamate E205 occupies the putative central chloride-binding site, indicating that our structure represents a closed state. Structural analysis, molecular dynamics and electrophysiological recordings identify key residues to interact with AK-42. Several AK-42 interacting residues are present in ClC-2 but not in other ClCs, providing a possible explanation for AK-42 specificity. Taken together, our results experimentally reveal the potential inhibition mechanism of ClC-2 inhibitor AK-42.

Indexed as

Chloride ChannelsCLC-2 Chloride ChannelsCell MembraneChloridesCryoelectron MicroscopyChloride ChannelsChloridesCLC-2 Chloride Channels

Identifiers

PMID37296152
PMCPMC10256776
OpenAlexW4379985222

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.